Trial Profile
A Two-part Open Label, Randomised, Single Dose, Crossover Study in Healthy Volunteers to: (Part A) Compare the Pharmacokinetics of up to 6 Chronocort® Formulations, and (Part B) Determine the Dose Proportionality of a Selected Chronocort® Formulation at Three Dose Levels With an Additional Comparison With the Selected Formulation Dosed on Two Occasions Over a 24 Hour Period
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Pharmacokinetics
- Sponsors Diurnal
- 17 Feb 2017 New trial record